Spinocerebellar Ataxia Type 11
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Spinocerebellar Ataxia Type 11

View Main Condition: Movement Disorders

What is the definition of Spinocerebellar Ataxia Type 11?
Spinocerebellar ataxia type 11 (SCA11) is characterized by progressive cerebellar ataxia (difficulty walking and balance) and abnormal eye signs (jerky pursuit, horizontal and vertical movements (nystagmus), pyramidal features (increased muscular tonus, increased reflexes and an abnormal reflex known as Babinski sign and inability to make to perform fine movements), peripheral neuropathy with numbness, weakness or pain in the feet or hands or other places of the body and dystonia. Diagnosis is based on signs and symptoms and is confirmed by genetic testing finding a change in the TTBK2 gene. It is inherited in an autosomal dominant manner.
What are the alternative names for Spinocerebellar Ataxia Type 11?
  • Spinocerebellar ataxia 11
  • SCA11
  • Spinocerebellar ataxia type 11
Who are the top Spinocerebellar Ataxia Type 11 Local Doctors?
Experienced in Spinocerebellar Ataxia Type 11
Family Medicine
Experienced in Spinocerebellar Ataxia Type 11
Family Medicine

Lakes Regional Healthcare

2301 Hwy 71 South, 
Spirit Lake, IA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Zachary Borus is a primary care provider, practicing in Family Medicine in Spirit Lake, Iowa. Dr. Borus is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 11. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bronchitis, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Endoscopy. Dr. Borus is board certified in American Board Of Family Medicine. Dr. Borus is currently accepting new patients.

Advanced in Spinocerebellar Ataxia Type 11
Advanced in Spinocerebellar Ataxia Type 11
Referral may be required

Reading Hospital Neurology Suite 104

2603 Keiser Blvd, Ste 104, 
Wyomissing, PA 
Languages Spoken:
English
Offers Telehealth

Dronacharya Lamichhane is a Neurologist practicing medicine in Wyomissing, Pennsylvania. Dr. Lamichhane is rated as an Advanced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 11. He is also highly rated in 64 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Secondary Parkinsonism, and Supranuclear Ocular Palsy. Dr. Lamichhane is board certified in American Board Of Psychiatry And Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Spinocerebellar Ataxia Type 11
Advanced in Spinocerebellar Ataxia Type 11
Referral required

Swedish Neuroscience Specialists - Movement Disorders

550 17th Avenue, Suite 540, 
Seattle, WA 
Languages Spoken:
English, Russian, Spanish, Vietnamese
Accepting New Patients
Offers Telehealth

Pravin Khemani is a Neurologist practicing medicine in Seattle, Washington. Dr. Khemani is rated as an Advanced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 11. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Essential Tremor, Deep Brain Stimulation, and Orchiectomy. Dr. Khemani is board certified in American Board Of Psychiatry And Neurology. Dr. Khemani is currently accepting new patients.

What are the latest Spinocerebellar Ataxia Type 11 Clinical Trials?
Coordination of Rare Diseases at Sanford

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center